Technology area: Biotechnology & Pharmaceuticals
3 pending office actions • 1 art units • 2 examiners • 0 of 3 (0%) have an AI response strategy ready • 1 patents granted in the last 365 days
Nuol Green Chemistry LLC is active in the Biotechnology & Pharmaceuticals technology area, where it currently manages 3 pending office actions. This sector is known for its rigorous examination standards and technical complexity. The company's prosecution efforts are shared between 2 distinct examiners, indicating a relatively concentrated point of contact for their pending intellectual property matters.
All current activity is localized within 1 distinct art unit. This concentration suggests that the company's patent filings are highly specialized and fall within a specific technical niche within the broader biotechnology field. For practitioners, this means that the success of the portfolio is heavily dependent on the specific interpretations and guidelines of this 1 art unit.
CUTLIFF, YATE KAI RENE is the busiest examiner for this portfolio, with 2 pending office actions currently assigned. Because this examiner handles a majority of the pending actions, their individual examination history and preferences will be a significant factor in the company's immediate prosecution outcomes. This arrangement allows for a focused legal strategy but also increases the impact of this examiner's specific decisions on the overall portfolio.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §101 + other | 1 (33%) |
| §102 only | 1 (33%) |
| §112 only | 1 (33%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| CUTLIFF, YATE KAI RENE | 2 | 79.8% | +24.3% |
| WITHERSPOON, SIKARL A | 1 | 86.3% | -20.1% |
Cases in front of an examiner with an allow rate of 80%+ where the difficulty is Easy or Medium. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18413539 | Synthesis of Triisoamyl Citrate (Triisopentanol) and its Applications as a Solvent, Plastizer and Component of Cosmetic and Aerosol Formulations | WITHERSPOON, SIKARL A | — |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18596120 | PROCESS FOR THE PRODUCTION OF FATTY ACIDS AND ISOMERIZED ESTERS | CUTLIFF, YATE KAI RENE | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 2 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18596120 | PROCESS FOR THE PRODUCTION OF FATTY ACIDS AND ISOMERIZED ESTERS | CUTLIFF, YATE KAI RENE | — |
| 18596175 | BIOMONOMERS AND THEIR RESPECTIVE BIOPOLYMERS FOR PAINTS AND VARNISHES | CUTLIFF, YATE KAI RENE | — |
| Art Unit | Apps |
|---|---|
| 1692 | 3 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18596120 | PROCESS FOR THE PRODUCTION OF FATTY ACIDS AND ISOMERIZED ESTERS | CUTLIFF, YATE KAI RENE | 1692 | §101§102§103§112 | Non-Final OA | — | Pending | Mar 05, 2024 |
| 18596175 | BIOMONOMERS AND THEIR RESPECTIVE BIOPOLYMERS FOR PAINTS AND VARNISHES | CUTLIFF, YATE KAI RENE | 1692 | §112 | Non-Final OA | — | Pending | Mar 05, 2024 |
| 18413539 | Synthesis of Triisoamyl Citrate (Triisopentanol) and its Applications as a Solvent, Plastizer and Component of Cosmetic and Aerosol Formulations | WITHERSPOON, SIKARL A | 1692 | §102 | Non-Final OA | — | Pending | Jan 16, 2024 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialNuol Green Chemistry LLC has 3 pending office actions as of October 2026, spread across 1 art units and 2 examiners.
Yate Kai Rene Cutliff has the most, with 2 of Nuol Green Chemistry LLC's pending office actions.
Mostly Biotechnology & Pharmaceuticals (USPTO Tech Center 1600), based on where its pending office actions are examined.
